{"id":4280,"date":"2024-10-17T05:30:15","date_gmt":"2024-10-17T09:30:15","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/"},"modified":"2026-09-24T00:05:50","modified_gmt":"2026-09-24T04:05:50","slug":"gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/","title":{"rendered":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO"},"content":{"rendered":"\nParis, France, le jeudi, 17 octobre 2024, 7h30 CET<\/strong> \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui que de nouvelles donn\u00e9es et analyses scientifiques relatives \u00e0 la th\u00e9rapie g\u00e9nique LUMEVOQ\u00ae<\/sup> seront pr\u00e9sent\u00e9es lors du congr\u00e8s annuel 2024 de l\u2019Acad\u00e9mie Am\u00e9ricaine d\u2019Ophtalmologie (AAO) qui se tient \u00e0 Chicago, Illinois, Etats-Unis, du 18 au 21 octobre 2024.\n\nDes experts dans le domaine de la Neuropathie Optique H\u00e9r\u00e9ditaire de Leber (NOHL) pr\u00e9senteront une analyse comparative entre l’histoire naturelle de la NOHL, id\u00e9b\u00e9none et LUMEVOQ\u00ae<\/sup>, des donn\u00e9es en vie r\u00e9elle de LUMEVOQ\u00ae<\/sup>, des r\u00e9sultats concernant l’effet controlat\u00e9ral, et des donn\u00e9es relatives aux effets \u00e0 long terme de l\u2019injection bilat\u00e9rale de LUMEVOQ\u00ae<\/sup>.\n\nPoster<\/u> : \u201c\u201cMeta-analysis of Treatment Outcomes for Patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy\u201d <\/em>(Poster PO004)\n
    \n \t
  • Pr\u00e9sent\u00e9 par : Nancy J. Newman, MD<\/strong>, Emory University School of Medicine, Atlanta, Georgie, Etats-Unis<\/li>\n \t
  • Date et heure : samedi 19 octobre 2024, de 9h15 \u00e0 10h15<\/strong> CDT<\/li>\n \t
  • Lieu : Hall A, Poster Theater<\/li>\n<\/ul>\nPr\u00e9sentation <\/u>: \u201cEfficacy and Safety of Lenadogene Nolparvovec Gene Therapy for LHON in Real-Life Settings<\/em>\u201d (PA023)\n
      \n \t
    • Pr\u00e9sent\u00e9e par : Valerie Biousse, MD<\/strong>, Emory University School of Medicine, Atlanta, Georgie, Etats-Unis<\/li>\n \t
    • Session: OP04 Neuro-Ophthalmology Original Papers<\/li>\n \t
    • Date et heure : samedi, 19 octobre 2024, de 14h48 \u2013 15h00 <\/strong>CDT<\/li>\n \t
    • Lieu : S405<\/li>\n<\/ul>\nPoster <\/u>: \u201cPost-Mortem Analyses with Histopathological and Molecular Assessments Following AAV2 Gene Therapy in LHON\u201d<\/em> (Poster PO093)\n
        \n \t
      • Pr\u00e9sent\u00e9 par : Alfredo A. Sadun, MD, PhD<\/strong>, Doheny Eye Centers-UCLA, Pasadena, Californie, Etats-Unis<\/li>\n \t
      • Date et heure : dimanche 20 octobre 2024, de 9h15 \u00e0 9h45 CDT<\/strong><\/li>\n \t
      • Lieu : Station 2, Poster Discussion Lobby<\/li>\n<\/ul>\nPr\u00e9sentation <\/u>: \u201cFour-Year Results of Bilateral Injection of Lenadogene Nolparvovec Gene Therapy for LHON<\/em>\u201d (PA047)\n
          \n \t
        • Pr\u00e9sent\u00e9e par : Patrick Yu-Wai-Man, FRCOphth, MBBS, PhD<\/strong>, Universit\u00e9 de Cambridge, Cambridge, Angleterre<\/li>\n \t
        • Session: OP08 Retina, Vitreous Original Papers<\/li>\n \t
        • Date et heure : dimanche 20 octobre 2024, de 14h48 \u00e0 14h55 CDT<\/strong><\/li>\n \t
        • Lieu : S405<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

          Paris, France, le jeudi, 17 octobre 2024, 7h30 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui que de nouvelles donn\u00e9es et analyses scientifiques relatives […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[73],"news-type":[74,75,77],"post-year":[],"class_list":["post-4280","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-gs010-lumevoq","news-type-product-candidates","news-type-clinical","news-type-conferences"],"acf":[],"yoast_head":"\nGenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le jeudi, 17 octobre 2024, 7h30 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui que de nouvelles donn\u00e9es et analyses scientifiques relatives […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-17T09:30:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:50+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO\",\"datePublished\":\"2024-10-17T09:30:15+00:00\",\"dateModified\":\"2026-09-24T04:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/\"},\"wordCount\":359,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/\",\"name\":\"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2024-10-17T09:30:15+00:00\",\"dateModified\":\"2026-09-24T04:05:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2024\\\/10\\\/17\\\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics","og_description":"Paris, France, le jeudi, 17 octobre 2024, 7h30 CET \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce aujourd\u2019hui que de nouvelles donn\u00e9es et analyses scientifiques relatives […]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/","og_site_name":"GenSight Biologics","article_published_time":"2024-10-17T09:30:15+00:00","article_modified_time":"2026-09-24T04:05:50+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO","datePublished":"2024-10-17T09:30:15+00:00","dateModified":"2026-09-24T04:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/"},"wordCount":359,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/","name":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2024-10-17T09:30:15+00:00","dateModified":"2026-09-24T04:05:50+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2024\/10\/17\/gensight-biologics-annonce-des-communications-scientifiques-sur-lumevoq-au-congres-2024-de-laao\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics annonce des communications scientifiques sur LUMEVOQ\u00ae au Congr\u00e8s 2024 de l\u2019AAO"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4280"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4280\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4280"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4280"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4280"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4280"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}